Tumors that arise from the endocrine pancreas, or the islets of pancreas, are called pancreatic neuroendocrine tumors (NETs). Pancreatic NET have an incidence of ＜0.1 per one million persons, and can lead to secretion of ectopic adrenocorticotropic hormone (ACTH). Herein, we presented a case of patient with Cushing's syndrome as a result of ACTH-producing pancreatic NET, who underwent successful laparoscopic distal pancreatosplenectomy. A 40-year-old Korean female patient with ophthalmologic discomfort, osteoporosis, and unexplained hypokalemia was admitted to our hospital. Under the suspicion of ACTH producing pancreatic NET after the diagnostic workup, we decided to perform surgical resection. Laparoscopic distal pancreatosplenectomy was performed; and the pathological examination revealed a 1.5 cm-sized grade 2 neuroendocrine tumor of the pancreas, which was encapsulated within the pancreatic parenchyma. After the operation, the patient no longer displayed cushingoid features. ACTH-producing pancreatic NET is rare, but can be one of the causes of Cushing's syndrome. Surgical resection is a feasible option in treating ACTH-producing pancreatic NET. 
INTRODUCTION
Tumors that arise from the endocrine pancreas, or the islets of pancreas, are called pancreatic neuroendocrine tumors (NETs). NETs account for 1-3% of pancreatic tumors; however, the incidence of NETs is reported to be on the rise. 1, 2 The most well-known functional NETs include gastrinoma, insulinoma, glucagonoma, somatostatinoma, and vasoactive intestinal peptide tumor (VIPoma).
However, NETs that produce ACTH have been reported, despite their lower prevalence than the other types of functional tumors. 3 Uncontrolled production of ACTH can lead to the increase in glucocorticoid level, resulting in Cushing's syndrome. More than 80% of Cushing's syndrome is associated with autonomous pituitary ACTH secretion; however, it is well documented that approximately 4-18% of Cushing's syndrome is due to ectopic ACTH secretion. 4 Pancreatic NET has an incidence of <0.1 per one million persons, and can lead to ectopic ACTH secretion. 5 In a review of 42 select cases of islet tumor, Clark et al. 6 reported that two-thirds of the patients presented with weight gain, acne, diabetes mellitus, and hypokalemic alkalosis. In Korea, Song et al. 7 previously reported a 52-year-old male patient with ACTH-producing pancreatic NET accompanying multiple liver metastases. However, the study was limited to understanding the natural courses of the tumor biology. Herein, we presented a case of a patient with Cushing's syndrome as a result of ACTH-producing pancreatic NET, who underwent successful laparoscopic distal pancreatosplenectomy, with a brief review of the relevant literature. (Fig. 3A) . No lymph node metastasis was noted (pT1N0M0). The resection margin was free from tumor.
Tumor cells were strongly positive for chromogranin A, synpatophysin, and ACTH in (Fig. 3B-D) .
The serum ACTH and cortisol values were restored to the normal cut-off values immediately after the surgical removal of the neuroendocrine tumor (Fig. 1C) . In correlation with the decreased cortisol level, the patient no longer displayed cushingoid features; and central obesity and the moon-face characteristic were improved significantly (Fig. 1B) .
DISCUSSION
Due to the rarity of ACTH-producing pancreatic NETs and difficulty of performing curative resection, only a few cases have been reported. 3, 6 In our patient, surgical removal of the functioning NET of the pancreas alleviated most of the symptoms associated with Cushing's syndrome. Most notably, the ACTH and cortisol level dropped almost immediately after the resection of the tumor. We summarized similar cases that have been previously reported in the literature (Table 1) .
Herein, we showed five selected patients from Clark's review of 42 patients with islet tumor. 6 Of the 42 cases, most of the patients (64%) were women with the mean The reported cases collectively suggest that most patients with pancreatic ACTH-producing pancreatic NET were females and initially presented with cushingoid features; however, further analysis is required to confirm these findings. As previously reported, the 5-year survival rate of patients with pancreatic islet cell tumor and Cushing's syndrome is 16% with frequent metastases. 6 Consequently, patient's progress must be closely monitored even after surgical removal. At the three-month follow-up post-surgery, our patient showed no symptoms of such manifestations. Currently, there is no unified treatment algorithm after curative resection. Therefore, follow-up study of our case will be helpful in understanding the natural course of resected ACTH-producing NET of the pancreas.
In summary, ACTH-producing pancreatic NET is rare, but can be one of the causes of Cushing's syndrome.
Based on the literature review, curative resection is difficult because of concomitant multiple liver metastases, and a significant number of cases are associated with lymph node metastasis; however, laparoscopic distal pancreatosplenectomy can be one of the options in treating left-sided ACTH-producing pancreatic NET.
